When classified by isotype of aPL, cancer patients in this current study had a higher proportion of test positivity when compared to controls for every isotype (LA (5.1% vs 1.5%), aCL (5.8% vs 0.0%) and aβ2GPI (13.9% vs 7.3%). Here, FASLG is linked to cancer.